🧪 Metformin Exercise Adaptation Interaction Simulator

Exercise-Induced Mitochondrial Biogenesis Signaling

Placeholder: endurance exercise activates PGC-1alpha to build new mitochondria.

• AMPK: Primary sensor (Placeholder short note)
• PGC-1α: Master regulator (Placeholder short note)
• 2–6 h: Response window (Placeholder short note)
• Biogenesis: Adaptation type (Placeholder short note)

Placeholder heading: exercise signaling cascade

Placeholder short paragraph describing AMPK/PGC-1alpha exercise signaling cascade.

Metformin's AMPK Overlap with the Exercise Pathway

Placeholder: metformin activates the same AMPK node exercise uses.

• AMPK activation: Mechanism (Placeholder short note)
• Skeletal muscle: Target organ (Placeholder short note)
• AMPK-PGC1α: Shared node (Placeholder short note)
• Biguanide: Drug class (Placeholder short note)

Placeholder heading: convergent pathway nodes

Placeholder short paragraph describing metformin and exercise convergence on AMPK.

Potential Blunting of Training Adaptation

Placeholder: co-administration may reduce mitochondrial adaptation gains.

• ~30–50%: Reported blunting (Placeholder short note)
• VO2max gain: Affected trait (Placeholder short note)
• RCT trials: Study design (Placeholder short note)
• Concurrent dosing: Risk driver (Placeholder short note)

Placeholder heading: blunted adaptation evidence

Placeholder short paragraph describing evidence for blunted training adaptation.

Placeholder highlight callout: blunting risk rises with concurrent high-intensity training.

Population-Specific Effect Size Differences

Placeholder: individual response to the interaction varies substantially.

• ~50/50: Responder split (Placeholder short note)
• SLC22A tx.: Genetic factor (Placeholder short note)
• Older > blunted: Age effect (Placeholder short note)
• Modifies effect: Fitness baseline (Placeholder short note)

Placeholder heading: variability across subgroups

Placeholder short paragraph describing population-specific variability drivers.

Timing Strategies to Minimize Interaction

Placeholder: separating metformin dosing from training may help.

• ≥3 h: Suggested gap (Placeholder short note)
• Dose separation: Strategy (Placeholder short note)
• Post-workout dose: Alt. strategy (Placeholder short note)
• Emerging: Evidence level (Placeholder short note)

Placeholder heading: practical timing recommendations

Placeholder short paragraph describing timing separation strategies.

Placeholder highlight callout: separating doses may preserve most training adaptation.